|
|
|
|
LEADER |
00000nab a2200000 i 4500 |
001 |
publ2338 |
005 |
20250307110911.0 |
008 |
250307s1998 hu o 0|| Angol d |
022 |
|
|
|a 0024-3205
|
024 |
7 |
|
|a 10.1016/S0024-3205(98)00544-X
|2 doi
|
024 |
7 |
|
|a 117447
|2 mtmt
|
040 |
|
|
|a PPKE Publikáció Repozitórium
|b hun
|
041 |
|
|
|a Angol
|
100 |
1 |
|
|a Rónai András
|
245 |
1 |
0 |
|a Diprotin A, an inhibitor of dipeptidyl aminopeptidase IV (EC3.4.14.5) produces naloxone-reversible analgesia in rats
|h [elektronikus dokumentum] /
|c Rónai András
|
260 |
|
|
|c 1998
|
300 |
|
|
|a 145-152
|
490 |
0 |
|
|a LIFE SCIENCES
|v 64 No. 2
|
520 |
3 |
|
|a The dipeptidyl aminopeptidase IV (DP IV) inhibitor Diprotin A produces st full, dose-dependent, short-lasting and naloxone- reversible analgesia in the rat tail-flick test when given intracerebroventricularly, with an ED50 of 295 nmol/rat but it has no direct opioid agonist activity in the longitudinal muscle strip of guinea-pig ileum bioassay. Two of the potential DP IV substrates, morphiceptin and endomorphin 1, identified recently in bovine brain were also analgesic given by similar route. The action of endomorphin 1 was more potent (ED50 = 7.9 nmol/rat) and slightly but significantly more sustained than that of Diprotin A. Diprotin A neither potentiated nor prolonged the effect of a marginally analgesic dose of endomorphin 1. The distinct time course and the lack of potentiation indicate that in the analgesic effect of Diprotin A. in rats the protection of a brain Tyr-Pro-peptide other than endomorphin 1 is involved.
|
650 |
|
4 |
|a Farmakológia és gyógyszerészet
|
700 |
0 |
1 |
|a Timár Júlia
|e aut
|
700 |
0 |
1 |
|a Mako E
|e aut
|
700 |
0 |
1 |
|a Erdő Franciska
|e aut
|
700 |
0 |
1 |
|a Gyarmati Zsuzsanna
|e aut
|
700 |
0 |
1 |
|a Tóth Géza
|e aut
|
700 |
0 |
1 |
|a Orosz György
|e aut
|
700 |
0 |
1 |
|a Fürst Zsuzsanna
|e aut
|
700 |
0 |
1 |
|a Székely József Iván
|e aut
|
856 |
4 |
0 |
|u https://publikacio.ppke.hu/id/eprint/2338/1/lifescience1999.pdf
|z Dokumentum-elérés
|